Loading insider details...
Beta
Latest Form 4 (Sep 21, 2026): Exercise/Conversion of 10,000 ORKA shares, $78.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 10,000 | $78.0K |
| Sep 15, 2026 | Oruka Therapeutics, Inc. (ORKA) | Sale | 1,039 | $99.4K |
| Aug 14, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 10,000 | $78.0K |
| Jun 15, 2026 | Oruka Therapeutics, Inc. (ORKA) | Sale | 733 | $51.1K |
| Mar 17, 2026 | Oruka Therapeutics, Inc. (ORKA) | Sale | 733 | $30.3K |
| Jan 23, 2026 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 32,500 | n/a |
| Jan 24, 2025 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 162,500 | n/a |
| Mar 22, 2024 | CymaBay Therapeutics, Inc. (CBAY) | Disposition to Issuer | 41,824 | n/a |
| Mar 15, 2024 | CymaBay Therapeutics, Inc. (CBAY) | Exercise/Conversion | 41,824 | $330.0K |
| Jan 26, 2024 | CymaBay Therapeutics, Inc. (CBAY) | Grant/Award | 28,438 | n/a |